Prostate-specific antigen-reactive cytotoxic T lymphocyte precursors in colon cancer patients

Oncology Reports

Volumn 15, Issue 2, 2006, Pages 317-321

  Wang, Yi ^a,b   Harada, Mamoru ^a,c   Yano, Hirohisa ^c   Ogasawara, Sachiko ^c   Tanaka, Masahiro ^c   Yamada, Akira ^a   Itoh, Kyogo ^a,c  

^a KURUME UNIVERSITY   (Japan)

^b JILIN UNIVERSITY   (China)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Colon cancer; Cytotoxic T lymphocytes; Peptide; Prostate specific antigen

Indexed keywords

MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; COLON TUMOR; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MALE; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; TUMOR CELL LINE;

CELL LINE, TUMOR; COLONIC NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROSTATE-SPECIFIC ANTIGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEM CELLS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 33744459793     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Stenman UH, Leinonen J, Zhang WM and Finne P: Prostate-specific antigen. Semin Cancer Biol 9: 83-93, 1999. (Pubitemid 29265524)
2. Oesterling JE: Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 145: 907-923, 1991.
3. Epstein JI: PSA and PAP as immunohistochemical markers in prostate cancer. Urol Clin North Am 20: 757-770, 1993.
4. Armbruster DA: Prostate-specific antigen: biochemistry, analytical methods, and clinical application. Clin Chem 39: 181-195, 1993.
5. Bostwick DG: Prostate-specific antigen. Current role in diagnostic pathology of prostatic cancer. Am J Clin Pathol 102: S31-S37, 1994.
6. Roos AK, Pavlenko M, Charo J, Egevad L and Pisa P: Induction of PSA-specific CTLs and anti-tumor immunity by a genetic prostate cancer vaccine. Prostate 62: 217-223, 2005. (Pubitemid 40129059)
7. Ploch NR and Brawer MK: How to use prostate-specific antigen. Urology 43: 27-35, 1994.
8. Pavlenko M, Roos AK, Lundqvist A, et al: A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer. Br J Cancer 91: 688-694, 2004. (Pubitemid 39141625)
9. Harada M, Kobayashi K, Matsueda S, Nakagawa M, Noguchi M and Itoh K: Prostate-specific antigen-derived epitopes capable of inducing cellular and humeral responses in HLA-A24+ prostate cancer patients. Prostate 57: 152-159, 2003. (Pubitemid 37204496)
10. Perambakam S, Xue BH, Sosman JA and Peace DJ: Induction of Tc2 cells with specificity for prostate-specific antigen from patients with hormone-refractory prostate cancer. Cancer Immunol Immunother 51: 263-270, 2002. (Pubitemid 34810707)
11. Clements J, Ward G, Kaushal A, Hi SI, Kennett C and Nicol D: A prostate-specific antigen-like protein associated with renal cell carcinoma in women. Clin Cancer Res 3: 1427-1431, 1997. (Pubitemid 27362406)
12. Takahashi T, Hoshi S, Satoh M, Kaneda T, Suzuki KI, Nakagawara KI and Orikasa S: The study of PSA gene expression on urogenital cell lines. Int J Urol 6: 526-531, 1999. (Pubitemid 29472037)
13. Breul J, Pickl U and Hartung R: Prostate-specific antigen in urine. Eur Urol 26: 18-21, 1994. (Pubitemid 24193915)
14. Yu H and Diamandis EP: Prostate-specific antigen in milk of lactating women. Clin Chem 41: 54-58, 1995.
15. Yu H and Diamandis EP: Measurement of serum prostate-specific antigen levels in women and in prostatectomized men with an ultrasensitive immunoassay technique. J Urol 153: 1004-1008, 1995.
16. Yu H, Giai M, Diamandis EP, et al: Prostate specific antigen is a new favorable prognostic indicator for women with breast cancer. Cancer Res 55: 2104-2110, 1995.
17. Diamandis EP and Yu H: Nonprostatic sources of prostate-specific antigen. Urol Clin North Am 24: 275-282, 1997. (Pubitemid 27169251)
18. Zarghami N, D'Costa M, Tsuyuki D, Asa SL and Diamandis EP: Expression of the prostate specific antigen gene by lung tissue. Clin Cancer Res 3: 1201-1206, 1997. (Pubitemid 27319767)
19. Levesque M, Hu H, D'Costa M and Diamandis EP: Prostate-specific antigen expression by various tumors. J Clin Lab Anal 9: 123-128, 1995.
20. Yamamoto M, Hibi H and Miyake K: Raised prostate-specific antigen in adenocarcinoma of the colon. Int Urol Nephrol 29: 221-225, 1997. (Pubitemid 27297100)
21. Duraker N, Can D and Parilti M: Measurement of serum total and free prostate-specific antigen in women with colorectal carcinoma. Br J Cancer 86: 203-206, 2002. (Pubitemid 34185146)
22. Correale P, Walmsley K, Nieroda C, Zaremba S, Zhu M, Schlom J and Tsang KY: In vitro generation of human cytotoxic T lymphocytes specific for peptides derived from prostate-specific antigen. J Natl Cancer Inst 89: 293-300, 1997. (Pubitemid 27085891)
23. Xue BH, Zhang Y, Sosman JA and Peace DJ: Induction of human cytotoxic T lymphocytes specific for prostate-specific antigen. Prostate 30: 73-78, 1997. (Pubitemid 27088114)
24. Corman JM, Sercarz EE and Nanda NK: Recognition of prostate specific antigenic peptide determinants by human CD4 and CD8 T cells. Clin Exp Immunol 114: 166-172, 1998. (Pubitemid 28505714)
25. Noguchi M, Itoh K, Yao A, et al: Immunological evaluation of individualized peptide vaccination with a low dose of estramustine for HLA-A24+ HRPC patients. Prostate 63: 1-12, 2005. (Pubitemid 40365385)
26. Yu H, Diamandis EP, Zarghami N and Grass L: Induction of prostate specific antigen production by steroids and tamoxifen in breast cancer cell lines. Breast Cancer Res Treat 32: 291-300, 1994. (Pubitemid 24351376)
27. Zarghami N, Grass L and Diamandis EP: Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer. Br J Cancer 75: 579-588, 1997. (Pubitemid 27085303)
28. Levesque MA, Clark GM, Yu H and Diamandis EP: Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumors and their association with other prognostic indicators. Br J Cancer 72: 720-727, 1995.
29. Meggouh F, Lointier P, Pezet D and Saez S: Status of sex steroid hormone receptors in large bowel cancer. Cancer 67: 1964-1970, 1991.
30. Singh S, Sheppard MC and Langman MJS: Sex differences in the incidence of colorectal cancer: an exploration of oestrogen and progesterone receptors. Gut 34: 611-615, 1993. (Pubitemid 23146883)
31. Korenaga D, Orita H, Maekawa S, Hasaka H, Ikeda T and Sugimachi K: Relationship between hormone receptor levels and cell-kinetics in human colorectal cancer. Hepatogastroenterology 44: 78-83, 1997. (Pubitemid 27096018)
32. Korenaga D, Orita H, Okuyama T, Kinoshita J, Maekawa S, Ikeda T and Sugimachi K: Sex hormone-receptor-negative tumors have a higher proliferative activity than sex hormone-receptor-positive tumors in human adenocarcinomas of the gastrointestinal tract. Surg Today 28: 1007-1014, 1998. (Pubitemid 28482055)
33. Renkvist N, Castelli C, Robbins PF and Parmiani G: A listing of human tumor antigens recognized by T cells. Cancer Immunol Immunother 50: 3-15, 2001. (Pubitemid 32250041)